MICHAEL R. DOUGHERTY - 03 Oct 2022 Form 4 Insider Report for IDERA PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Michael R. Dougherty
Issuer symbol
N/A
Transactions as of
03 Oct 2022
Net transactions value
+$21,938
Form type
4
Filing time
05 Oct 2022, 21:26:59 UTC
Previous filing
06 Jul 2022
Next filing
12 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDRA Common Stock Award $21,938 +58,516 +21% $0.3749 341,632 03 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees.